+Follow
3von
No personal profile
8
Follow
0
Followers
0
Topic
0
Badge
Posts
Hot
3von
2021-05-26
Pls help to like comment. Thanks
Sorry, the original content has been removed
3von
2021-05-26
Buy??
Don't Wait For a Market Crash: These 2 Top Stocks Are On Sale
3von
2021-05-26
.......
Sorry, the original content has been removed
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3574818783536051","uuid":"3574818783536051","gmtCreate":1611725386107,"gmtModify":1611725386107,"name":"3von","pinyin":"3von","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":8,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.26","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.36%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":136705126,"gmtCreate":1622038234565,"gmtModify":1704178319240,"author":{"id":"3574818783536051","authorId":"3574818783536051","name":"3von","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574818783536051","authorIdStr":"3574818783536051"},"themes":[],"htmlText":"Pls help to like comment. Thanks","listText":"Pls help to like comment. Thanks","text":"Pls help to like comment. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":6,"repostSize":0,"link":"https://ttm.financial/post/136705126","repostId":"1178711508","repostType":4,"repost":{"id":"1178711508","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1622035906,"share":"https://ttm.financial/m/news/1178711508?lang=&edition=fundamental","pubTime":"2021-05-26 21:31","market":"us","language":"en","title":"Stocks rise modestly at the open, reopening trades climb again","url":"https://stock-news.laohu8.com/highlight/detail?id=1178711508","media":"Tiger Newspress","summary":"U.S. stocks rose on Wednesday as shares tied to the economic reopening supported the broader market ","content":"<p>U.S. stocks rose on Wednesday as shares tied to the economic reopening supported the broader market once again.</p><p>The Dow Jones Industrial Average rose 79 points, while the S&P 500 gained 0.3%. The tech-heavy Nasdaq Composite added 0.3%. The S&P 500 sits just about 1.1% from a record with the major benchmark little changed for the month of May.</p><p>Shares of companies linked to a recovering economy gained. Carnival Corp rose about 1%. Bank of America shares were also higher. Royal Caribbean jumped 2% and brought its gain this week to 11% after the cruise line operator received approval to begin test cruises with volunteer passengers.</p><p>The optimism on the economycomes as U.S. average daily Covid cases fall below 25,000 and as nearly half the U.S. population has received at least one vaccination dose.</p><p>Shares of Ford rose more than 2% after the automobile giant said it is increasing its investment in electric vehicles by $30 billion through 2025.</p><p>Bitcoin continued its comeback, helping risk sentiment in the financial markets. Bitcoin climbed back above $40,000 on Wednesday, according to Coin Metrics. On May 19th, the cryptocurrency hit a low of 30,001.51 following an intraday crash of 30%. Shares of Tesla, a big holder of bitcoin, added 0.5% in premarket trading. Coinbase shares were also higher.</p><p>Investors will be keeping an eye on Washington and any developments on an infrastructure compromise that could boost the economy further. Senate Republicansplan to send President Joe Biden a counteroffer this weekcosts nearly $1 trillion.</p><p>Nordstromshares dropped about 6% in extended trading after the company missed the Street'sfirst-quarter earningsexpectations, while shares ofUrban Outfittersjumped more than 7% following better-than-expected quarterly results after the bell.</p><p>The market struggled to find direction Tuesday. Stocks edged higher early in the session, but ultimately closed lower. The S&P 500 dipped 0.2% as the energy sector lagged. The Nasdaq Composite closed flat while the Dow Jones Industrial Average dipped 81.52 points, or 0.2%.</p><p>Airline, cruise line and homebuilder stocks outperformed on Tuesday.United Airlinesjumped 1.5% after the carrier said domestic leisure fairstopped 2019 levels this month amid the reopening.Royal CaribbeanandNorwegian Cruise Lineshares each rose about 3.6%.NVRshares jumped about 4%.</p><p>The strong performance from reopening stocks suggests \"investors are also leaning into the normalcy,\" Goldman Sachs managing director Chris Hussey wrote in a note. \"The news on the recovery remains very encouraging in the US. And it's interesting to see that some stocks may have still not fully priced it in.\"</p><p>\"Low volatility, flat equities, declining US Treasury yields, and low trading volumes — feels a lot like a Tuesday during a pre-holiday week. In other words, this feels...normal,\" Hussey said.</p><p>Investors are awaiting a speech from Federal Reserve Vice Chair Randal Quarles on Wednesday as concerns surrounding inflation and potential tapering of asset purchases continue.</p><p>Chief executives of the country's largest banks — includingJPMorgan Chase,Bank of America,Citigroup,Wells Fargo,Goldman SachsandMorgan Stanley— are set to testify before the Senate Banking Committee on Wednesday morning.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks rise modestly at the open, reopening trades climb again</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks rise modestly at the open, reopening trades climb again\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-26 21:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stocks rose on Wednesday as shares tied to the economic reopening supported the broader market once again.</p><p>The Dow Jones Industrial Average rose 79 points, while the S&P 500 gained 0.3%. The tech-heavy Nasdaq Composite added 0.3%. The S&P 500 sits just about 1.1% from a record with the major benchmark little changed for the month of May.</p><p>Shares of companies linked to a recovering economy gained. Carnival Corp rose about 1%. Bank of America shares were also higher. Royal Caribbean jumped 2% and brought its gain this week to 11% after the cruise line operator received approval to begin test cruises with volunteer passengers.</p><p>The optimism on the economycomes as U.S. average daily Covid cases fall below 25,000 and as nearly half the U.S. population has received at least one vaccination dose.</p><p>Shares of Ford rose more than 2% after the automobile giant said it is increasing its investment in electric vehicles by $30 billion through 2025.</p><p>Bitcoin continued its comeback, helping risk sentiment in the financial markets. Bitcoin climbed back above $40,000 on Wednesday, according to Coin Metrics. On May 19th, the cryptocurrency hit a low of 30,001.51 following an intraday crash of 30%. Shares of Tesla, a big holder of bitcoin, added 0.5% in premarket trading. Coinbase shares were also higher.</p><p>Investors will be keeping an eye on Washington and any developments on an infrastructure compromise that could boost the economy further. Senate Republicansplan to send President Joe Biden a counteroffer this weekcosts nearly $1 trillion.</p><p>Nordstromshares dropped about 6% in extended trading after the company missed the Street'sfirst-quarter earningsexpectations, while shares ofUrban Outfittersjumped more than 7% following better-than-expected quarterly results after the bell.</p><p>The market struggled to find direction Tuesday. Stocks edged higher early in the session, but ultimately closed lower. The S&P 500 dipped 0.2% as the energy sector lagged. The Nasdaq Composite closed flat while the Dow Jones Industrial Average dipped 81.52 points, or 0.2%.</p><p>Airline, cruise line and homebuilder stocks outperformed on Tuesday.United Airlinesjumped 1.5% after the carrier said domestic leisure fairstopped 2019 levels this month amid the reopening.Royal CaribbeanandNorwegian Cruise Lineshares each rose about 3.6%.NVRshares jumped about 4%.</p><p>The strong performance from reopening stocks suggests \"investors are also leaning into the normalcy,\" Goldman Sachs managing director Chris Hussey wrote in a note. \"The news on the recovery remains very encouraging in the US. And it's interesting to see that some stocks may have still not fully priced it in.\"</p><p>\"Low volatility, flat equities, declining US Treasury yields, and low trading volumes — feels a lot like a Tuesday during a pre-holiday week. In other words, this feels...normal,\" Hussey said.</p><p>Investors are awaiting a speech from Federal Reserve Vice Chair Randal Quarles on Wednesday as concerns surrounding inflation and potential tapering of asset purchases continue.</p><p>Chief executives of the country's largest banks — includingJPMorgan Chase,Bank of America,Citigroup,Wells Fargo,Goldman SachsandMorgan Stanley— are set to testify before the Senate Banking Committee on Wednesday morning.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178711508","content_text":"U.S. stocks rose on Wednesday as shares tied to the economic reopening supported the broader market once again.The Dow Jones Industrial Average rose 79 points, while the S&P 500 gained 0.3%. The tech-heavy Nasdaq Composite added 0.3%. The S&P 500 sits just about 1.1% from a record with the major benchmark little changed for the month of May.Shares of companies linked to a recovering economy gained. Carnival Corp rose about 1%. Bank of America shares were also higher. Royal Caribbean jumped 2% and brought its gain this week to 11% after the cruise line operator received approval to begin test cruises with volunteer passengers.The optimism on the economycomes as U.S. average daily Covid cases fall below 25,000 and as nearly half the U.S. population has received at least one vaccination dose.Shares of Ford rose more than 2% after the automobile giant said it is increasing its investment in electric vehicles by $30 billion through 2025.Bitcoin continued its comeback, helping risk sentiment in the financial markets. Bitcoin climbed back above $40,000 on Wednesday, according to Coin Metrics. On May 19th, the cryptocurrency hit a low of 30,001.51 following an intraday crash of 30%. Shares of Tesla, a big holder of bitcoin, added 0.5% in premarket trading. Coinbase shares were also higher.Investors will be keeping an eye on Washington and any developments on an infrastructure compromise that could boost the economy further. Senate Republicansplan to send President Joe Biden a counteroffer this weekcosts nearly $1 trillion.Nordstromshares dropped about 6% in extended trading after the company missed the Street'sfirst-quarter earningsexpectations, while shares ofUrban Outfittersjumped more than 7% following better-than-expected quarterly results after the bell.The market struggled to find direction Tuesday. Stocks edged higher early in the session, but ultimately closed lower. The S&P 500 dipped 0.2% as the energy sector lagged. The Nasdaq Composite closed flat while the Dow Jones Industrial Average dipped 81.52 points, or 0.2%.Airline, cruise line and homebuilder stocks outperformed on Tuesday.United Airlinesjumped 1.5% after the carrier said domestic leisure fairstopped 2019 levels this month amid the reopening.Royal CaribbeanandNorwegian Cruise Lineshares each rose about 3.6%.NVRshares jumped about 4%.The strong performance from reopening stocks suggests \"investors are also leaning into the normalcy,\" Goldman Sachs managing director Chris Hussey wrote in a note. \"The news on the recovery remains very encouraging in the US. And it's interesting to see that some stocks may have still not fully priced it in.\"\"Low volatility, flat equities, declining US Treasury yields, and low trading volumes — feels a lot like a Tuesday during a pre-holiday week. In other words, this feels...normal,\" Hussey said.Investors are awaiting a speech from Federal Reserve Vice Chair Randal Quarles on Wednesday as concerns surrounding inflation and potential tapering of asset purchases continue.Chief executives of the country's largest banks — includingJPMorgan Chase,Bank of America,Citigroup,Wells Fargo,Goldman SachsandMorgan Stanley— are set to testify before the Senate Banking Committee on Wednesday morning.","news_type":1},"isVote":1,"tweetType":1,"viewCount":655,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":136706413,"gmtCreate":1622038163132,"gmtModify":1704178316616,"author":{"id":"3574818783536051","authorId":"3574818783536051","name":"3von","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574818783536051","authorIdStr":"3574818783536051"},"themes":[],"htmlText":"Buy??","listText":"Buy??","text":"Buy??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/136706413","repostId":"2138511164","repostType":4,"isVote":1,"tweetType":1,"viewCount":582,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":136708576,"gmtCreate":1622038137495,"gmtModify":1704178315638,"author":{"id":"3574818783536051","authorId":"3574818783536051","name":"3von","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574818783536051","authorIdStr":"3574818783536051"},"themes":[],"htmlText":".......","listText":".......","text":".......","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/136708576","repostId":"2138148838","repostType":4,"repost":{"id":"2138148838","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1622036727,"share":"https://ttm.financial/m/news/2138148838?lang=&edition=fundamental","pubTime":"2021-05-26 21:45","market":"us","language":"en","title":"Mondelez to buy Greek snacking company Chipita for about $2 bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2138148838","media":"Reuters","summary":"May 26 (Reuters) - Mondelez International Inc said on Wednesday it would buy Greek food company Chip","content":"<p>May 26 (Reuters) - Mondelez International Inc said on Wednesday it would buy Greek food company Chipita S.A. for about $2 billion, as the Cadbury chocolate-maker expands its fast-growing snacking business.</p>\n<p>Chipita, which houses croissant and baked snack brands, including 7Days, Chipicao and Fineti, brought in about $580 million in revenue last year and is also expected to help Mondelez grow its presence in the Central and Eastern European markets.</p>\n<p>Mondelez has been building up its snacking portfolio to cash in on the surge in demand from people staying at home during COVID-19 lockdowns.</p>\n<p>Earlier this year, Mondelez acquired Australian food company Gourmet Food Holdings, healthy snacks maker Hu Master Holdings and also bought a majority stake in UK protein bar and snack company Grenade.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mondelez to buy Greek snacking company Chipita for about $2 bln</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMondelez to buy Greek snacking company Chipita for about $2 bln\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-05-26 21:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>May 26 (Reuters) - Mondelez International Inc said on Wednesday it would buy Greek food company Chipita S.A. for about $2 billion, as the Cadbury chocolate-maker expands its fast-growing snacking business.</p>\n<p>Chipita, which houses croissant and baked snack brands, including 7Days, Chipicao and Fineti, brought in about $580 million in revenue last year and is also expected to help Mondelez grow its presence in the Central and Eastern European markets.</p>\n<p>Mondelez has been building up its snacking portfolio to cash in on the surge in demand from people staying at home during COVID-19 lockdowns.</p>\n<p>Earlier this year, Mondelez acquired Australian food company Gourmet Food Holdings, healthy snacks maker Hu Master Holdings and also bought a majority stake in UK protein bar and snack company Grenade.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MDLZ":"亿滋"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2138148838","content_text":"May 26 (Reuters) - Mondelez International Inc said on Wednesday it would buy Greek food company Chipita S.A. for about $2 billion, as the Cadbury chocolate-maker expands its fast-growing snacking business.\nChipita, which houses croissant and baked snack brands, including 7Days, Chipicao and Fineti, brought in about $580 million in revenue last year and is also expected to help Mondelez grow its presence in the Central and Eastern European markets.\nMondelez has been building up its snacking portfolio to cash in on the surge in demand from people staying at home during COVID-19 lockdowns.\nEarlier this year, Mondelez acquired Australian food company Gourmet Food Holdings, healthy snacks maker Hu Master Holdings and also bought a majority stake in UK protein bar and snack company Grenade.","news_type":1},"isVote":1,"tweetType":1,"viewCount":431,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":136705126,"gmtCreate":1622038234565,"gmtModify":1704178319240,"author":{"id":"3574818783536051","authorId":"3574818783536051","name":"3von","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574818783536051","authorIdStr":"3574818783536051"},"themes":[],"htmlText":"Pls help to like comment. Thanks","listText":"Pls help to like comment. Thanks","text":"Pls help to like comment. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":6,"repostSize":0,"link":"https://ttm.financial/post/136705126","repostId":"1178711508","repostType":4,"isVote":1,"tweetType":1,"viewCount":655,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":136706413,"gmtCreate":1622038163132,"gmtModify":1704178316616,"author":{"id":"3574818783536051","authorId":"3574818783536051","name":"3von","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574818783536051","authorIdStr":"3574818783536051"},"themes":[],"htmlText":"Buy??","listText":"Buy??","text":"Buy??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/136706413","repostId":"2138511164","repostType":4,"repost":{"id":"2138511164","pubTimestamp":1622036700,"share":"https://ttm.financial/m/news/2138511164?lang=&edition=fundamental","pubTime":"2021-05-26 21:45","market":"us","language":"en","title":"Don't Wait For a Market Crash: These 2 Top Stocks Are On Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2138511164","media":"Motley Fool","summary":"At current levels, these two excellent companies are a bargain.","content":"<p>Waiting for a stock to bottom out before picking up its shares at a discount -- a practice known as timing the market -- is almost impossible to pull off consistently. Investors would have to know precisely when shares of a company have reached rock bottom, and for anyone who can always know that in advance, a career in fortune telling might be more lucrative than investing in stocks. Another way to buy stocks at a discount is to wait for a market crash.</p><p>After all, great companies will recover from a downturn, and those smart enough to hold their shares through thick and thin can be handsomely rewarded. If you don't have time to wait for the market to plunge, look for great stocks that have been under pressure of late, but whose businesses and long-term prospects remain intact. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a> such companies are <b>Vertex Pharmaceuticals</b> (NASDAQ:VRTX) and <b>Shopify</b> (NYSE:SHOP).</p><h2>1. Vertex Pharmaceuticals</h2><p>Shares of biotech giant Vertex Pharmaceuticals are down a mere 3.9% over the past three months, compared to gains of 7.3% for the <b>S&P 500</b>. But that alone doesn't tell the whole story of the drugmaker's recent woes. In October 2020, Vertex's stock dropped precipitously in <a href=\"https://laohu8.com/S/AONE\">one</a> day after the company announced its decision to discontinue the development of VX-814, a potential treatment for alpha-1 antitrypsin deficiency (AATD).</p><p>The company's decision came after it observed elevated liver enzymes in several AATD patients in a midstage trial for VX-814. But this market reaction may have been a bit overblown. For <a href=\"https://laohu8.com/S/AONE.U\">one</a>, Vertex is known primarily for its drugs that treat the underlying causes of cystic fibrosis (CF), a rare genetic condition that affects a patient's internal organs.</p><p>Vertex's most important CF drug, Trikafta, has a patent that will be valid until 2037. Trikafta can treat about 90% of the CF population. Even if competitors -- some of whom are looking to develop competing CF drugs -- manage to enter this market, thanks to its first-mover advantage, Vertex will likely remain the leader in this space for the foreseeable future.</p><p>Also, while VX-814 may have helped diversify its revenue stream away from Trikafta and other CF medicines, Vertex has other promising pipeline products that could do just that. There is VX-864, another potential drug for AATD, which, according to the company, is \"structurally different\" from VX-814. In other words, the failure of the former is not at all indicative of what may happen to the latter. Vertex said it expects to release data from a phase 2 clinical trial for VX-864 in the first half of this year.</p><p>Then there is CTX001, a potential gene editing therapy for transfusion-dependent beta-thalassemia (TDT) and sickle cell disease (SCD) the company is developing in collaboration with <b>CRISPR Therapeutics</b>. CTX001 has shown success in preventing vaso-occlusive crises (a side effect of SCD that causes acute pain) in several patients, among other positive results.</p><p>Management believes regulatory submission for CTX001 could happen within the next 18 to 24 months. Further, Vertex is an ambitious company with several more pipeline candidates, including one targeted at type 1 diabetes. And if that seems like too much of a long shot, consider that the biotech generated a little more than $3 billion in free cash flow over the trailing 12-month period.</p><p>If none of its current programs pan out (which seems unlikely), expect Vertex to go out and purchase the rights to others -- or even acquire a smaller biotech with a rich and promising pipeline. The combination of all those factors makes Vertex a biotech stock still worth buying.</p><h2>2. Shopify</h2><p>In the past few months, the market hasn't been kind to high-flying growth stocks. Shares of e-commerce giant Shopify -- a market favorite and growth stock extraordinaire -- are down by 11.38% since late February. How long will the market keep Shopify down? I am not sure, but as a shareholder, I feel just fine. Shopify remains one of my highest conviction holdings for two simple reasons. First, there is the growth of the e-commerce industry.</p><p>Despite many investors and analysts preaching the death of brick and mortar businesses, these businesses are not quite dead yet. Sure, many traditional retailers are struggling, but online transactions still make up a small percentage of total transactions in the U.S. According to the U.S. Department of Commerce, e-commerce sales accounted for just 13.4% of total sales during the first quarter of 2021.</p><p>Keep in mind, e-commerce penetration is even lower in many other parts of the world, particularly in less developed nations. In other words, this space can still grow by leaps and bounds, and Shopify and its peers can continue to profit for many years (and potentially decades) to come.</p><p>Then there is Shopify's \"sticky\" business model: that is, one which is constructed in such a way as to retain customers, thereby creating a growing source of recurring revenue. Think about the amount of work it takes to create a storefront from scratch (which is what Shopify offers merchants on its platform), particularly for those who aren't tech or internet-savvy.</p><p>But that's just the first step -- then, a business owner has to attract customers to its shiny, new online presence. Merchants on Shopify's platform also rely on the company for a plethora of other services, including billing, shipping, and more. Once an entrepreneur has gone through all this trouble, the incentive to switch to one of Shopify's competitors is pretty low.</p><p>This isn't just a matter of convenience either, although that's part of it. But the process could actually be harmful to the business. This powerful source of a competitive advantage is why I am confident Shopify will keep most of its clients while continuously adding new ones. And that can only mean great news for the company's revenue, profits, and stock market performance in the long run.</p><p>In five years or so, we may look at the recent market turmoil as a great buying opportunity for Shopify.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Don't Wait For a Market Crash: These 2 Top Stocks Are On Sale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDon't Wait For a Market Crash: These 2 Top Stocks Are On Sale\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-26 21:45 GMT+8 <a href=https://www.fool.com/investing/2021/05/26/dont-wait-for-a-market-crash-these-2-top-stocks-ar/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Waiting for a stock to bottom out before picking up its shares at a discount -- a practice known as timing the market -- is almost impossible to pull off consistently. Investors would have to know ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/26/dont-wait-for-a-market-crash-these-2-top-stocks-ar/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VERX":"Vertex, Inc.","SHOP":"Shopify Inc"},"source_url":"https://www.fool.com/investing/2021/05/26/dont-wait-for-a-market-crash-these-2-top-stocks-ar/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2138511164","content_text":"Waiting for a stock to bottom out before picking up its shares at a discount -- a practice known as timing the market -- is almost impossible to pull off consistently. Investors would have to know precisely when shares of a company have reached rock bottom, and for anyone who can always know that in advance, a career in fortune telling might be more lucrative than investing in stocks. Another way to buy stocks at a discount is to wait for a market crash.After all, great companies will recover from a downturn, and those smart enough to hold their shares through thick and thin can be handsomely rewarded. If you don't have time to wait for the market to plunge, look for great stocks that have been under pressure of late, but whose businesses and long-term prospects remain intact. Two such companies are Vertex Pharmaceuticals (NASDAQ:VRTX) and Shopify (NYSE:SHOP).1. Vertex PharmaceuticalsShares of biotech giant Vertex Pharmaceuticals are down a mere 3.9% over the past three months, compared to gains of 7.3% for the S&P 500. But that alone doesn't tell the whole story of the drugmaker's recent woes. In October 2020, Vertex's stock dropped precipitously in one day after the company announced its decision to discontinue the development of VX-814, a potential treatment for alpha-1 antitrypsin deficiency (AATD).The company's decision came after it observed elevated liver enzymes in several AATD patients in a midstage trial for VX-814. But this market reaction may have been a bit overblown. For one, Vertex is known primarily for its drugs that treat the underlying causes of cystic fibrosis (CF), a rare genetic condition that affects a patient's internal organs.Vertex's most important CF drug, Trikafta, has a patent that will be valid until 2037. Trikafta can treat about 90% of the CF population. Even if competitors -- some of whom are looking to develop competing CF drugs -- manage to enter this market, thanks to its first-mover advantage, Vertex will likely remain the leader in this space for the foreseeable future.Also, while VX-814 may have helped diversify its revenue stream away from Trikafta and other CF medicines, Vertex has other promising pipeline products that could do just that. There is VX-864, another potential drug for AATD, which, according to the company, is \"structurally different\" from VX-814. In other words, the failure of the former is not at all indicative of what may happen to the latter. Vertex said it expects to release data from a phase 2 clinical trial for VX-864 in the first half of this year.Then there is CTX001, a potential gene editing therapy for transfusion-dependent beta-thalassemia (TDT) and sickle cell disease (SCD) the company is developing in collaboration with CRISPR Therapeutics. CTX001 has shown success in preventing vaso-occlusive crises (a side effect of SCD that causes acute pain) in several patients, among other positive results.Management believes regulatory submission for CTX001 could happen within the next 18 to 24 months. Further, Vertex is an ambitious company with several more pipeline candidates, including one targeted at type 1 diabetes. And if that seems like too much of a long shot, consider that the biotech generated a little more than $3 billion in free cash flow over the trailing 12-month period.If none of its current programs pan out (which seems unlikely), expect Vertex to go out and purchase the rights to others -- or even acquire a smaller biotech with a rich and promising pipeline. The combination of all those factors makes Vertex a biotech stock still worth buying.2. ShopifyIn the past few months, the market hasn't been kind to high-flying growth stocks. Shares of e-commerce giant Shopify -- a market favorite and growth stock extraordinaire -- are down by 11.38% since late February. How long will the market keep Shopify down? I am not sure, but as a shareholder, I feel just fine. Shopify remains one of my highest conviction holdings for two simple reasons. First, there is the growth of the e-commerce industry.Despite many investors and analysts preaching the death of brick and mortar businesses, these businesses are not quite dead yet. Sure, many traditional retailers are struggling, but online transactions still make up a small percentage of total transactions in the U.S. According to the U.S. Department of Commerce, e-commerce sales accounted for just 13.4% of total sales during the first quarter of 2021.Keep in mind, e-commerce penetration is even lower in many other parts of the world, particularly in less developed nations. In other words, this space can still grow by leaps and bounds, and Shopify and its peers can continue to profit for many years (and potentially decades) to come.Then there is Shopify's \"sticky\" business model: that is, one which is constructed in such a way as to retain customers, thereby creating a growing source of recurring revenue. Think about the amount of work it takes to create a storefront from scratch (which is what Shopify offers merchants on its platform), particularly for those who aren't tech or internet-savvy.But that's just the first step -- then, a business owner has to attract customers to its shiny, new online presence. Merchants on Shopify's platform also rely on the company for a plethora of other services, including billing, shipping, and more. Once an entrepreneur has gone through all this trouble, the incentive to switch to one of Shopify's competitors is pretty low.This isn't just a matter of convenience either, although that's part of it. But the process could actually be harmful to the business. This powerful source of a competitive advantage is why I am confident Shopify will keep most of its clients while continuously adding new ones. And that can only mean great news for the company's revenue, profits, and stock market performance in the long run.In five years or so, we may look at the recent market turmoil as a great buying opportunity for Shopify.","news_type":1},"isVote":1,"tweetType":1,"viewCount":582,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":136708576,"gmtCreate":1622038137495,"gmtModify":1704178315638,"author":{"id":"3574818783536051","authorId":"3574818783536051","name":"3von","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574818783536051","authorIdStr":"3574818783536051"},"themes":[],"htmlText":".......","listText":".......","text":".......","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/136708576","repostId":"2138148838","repostType":4,"isVote":1,"tweetType":1,"viewCount":431,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
